Clinical Trial Update: The Effect of an RBAC Supplement (BRM4) on NAFLD [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of the RBAC supplement BRM4 on Non-Alcoholic Fatty Liver Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• BRM4 (RBAC supplement)

Snippet

Sponsor: University of Miami | Conditions: Non-Alcoholic Fatty Liver Disease | NA | Status: COMPLETED